645 related articles for article (PubMed ID: 28062374)
21. Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.
De Filippis B; Valenti D; de Bari L; De Rasmo D; Musto M; Fabbri A; Ricceri L; Fiorentini C; Laviola G; Vacca RA
Free Radic Biol Med; 2015 Jun; 83():167-77. PubMed ID: 25708779
[TBL] [Abstract][Full Text] [Related]
22. [MECP2 gene mutations in twenty-six cases with atypical Rett syndrome].
Li MR; Pan H; Bao XH; Zhang YZ; Jiang SL; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):285-8. PubMed ID: 16780651
[TBL] [Abstract][Full Text] [Related]
23. Generation and analysis of the Rett syndrome-associated MeCP2- null rat model.
Zhai W; Hu HX; Le L; Zhuang FF; Wang KZ; Zhao Y; Wang K; Liu XM; Sun D; Wang XY; Kuang SH; Hu KP
Yi Chuan; 2016 Nov; 38(11):1004-1011. PubMed ID: 27867150
[TBL] [Abstract][Full Text] [Related]
24. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
25. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.
Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC
Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109
[TBL] [Abstract][Full Text] [Related]
26. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
27. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.
Zhao D; Mokhtari R; Pedrosa E; Birnbaum R; Zheng D; Lachman HM
Mol Autism; 2017; 8():17. PubMed ID: 28367307
[TBL] [Abstract][Full Text] [Related]
29. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
30. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
31. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
32. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
Kao FC; Su SH; Carlson GC; Liao W
Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
[TBL] [Abstract][Full Text] [Related]
33. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
34. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.
Cuddapah VA; Pillai RB; Shekar KV; Lane JB; Motil KJ; Skinner SA; Tarquinio DC; Glaze DG; McGwin G; Kaufmann WE; Percy AK; Neul JL; Olsen ML
J Med Genet; 2014 Mar; 51(3):152-8. PubMed ID: 24399845
[TBL] [Abstract][Full Text] [Related]
35. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
36. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
37. Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.
Leoncini S; De Felice C; Signorini C; Zollo G; Cortelazzo A; Durand T; Galano JM; Guerranti R; Rossi M; Ciccoli L; Hayek J
Oxid Med Cell Longev; 2015; 2015():421624. PubMed ID: 26236424
[TBL] [Abstract][Full Text] [Related]
38. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome.
Le Thi Thanh H; Do Thi Diem T; Duy CV; Thanh HLT; Phuong HBT; Thanh LN
BMC Med Genet; 2018 Aug; 19(1):137. PubMed ID: 30081849
[TBL] [Abstract][Full Text] [Related]
40. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
Bissonnette JM; Knopp SJ
Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]